Figure 10
From: PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Genetic alteration analysis of PRKCSH by cBioPortal. (A) The alteration frequency distribution of different mutation types of PRKCSH in different tumors. (B) Presentation of the types, sites, and case number of PRKCSH genetic alteration across protein domains. (C) Patients without the alteration of PRKCSH had a better prognosis in DFS.
